XFB-19

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameXFB-19
Drug Alias NameXFB-19
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCCAAT/enhancer-binding protein beta inhibitors
TargetsCCAAT/enhancer-binding protein beta
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesXfibra Inc
China Registration ClassN/A

Develop Information

Active CompaniesXfibra Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A